Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytek Biosciences (CTKB)
NASDAQ:CTKB
CTKB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.66 - $9.33
Previous CloseN/A
Volume141.86K
Average Volume (3M)837.93K
Market Cap
$669.82M
Enterprise Value$491.90M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.07
Next Earnings
Feb 27, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding128,810,610
10 Day Avg. Volume810,349
30 Day Avg. Volume837,932
Standard Deviation0.19
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.43
Price to Cash Flow (P/CF)13.10
P/FCF Ratio14.10
Enterprise Value/Market Cap0.73
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.50
Enterprise Value/Ebitda-92.93
Forecast
1Y Price Target
$7.50Price Target Upside44.23% Upside
Rating ConsensusHold
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Market PerformanceSolid quarter driven by momentum in international markets and robust growth in service revenue.
Product DemandStrong demand observed for the Aurora Cell Sorter, indicating healthy market interest.
ProfitabilityCytek reiterated their expectations for FY24 positive cash flow from operations as they march towards consistent profitability.
Bears Say
CompetitionIncreased competition from companies with larger R&D budgets and commercial reach is impacting Cytek Biosciences' ability to gain market share.
GeopoliticalChallenges are anticipated in CTKB's global academic and government end market due to geopolitical concerns and NIH funding visibility.
RevenueCTKB's sales have been impacted by Becton Dickinson's new S8 Cell Sorter launch, leading to a preliminary revenue miss.
---
Ownership Overview
9.22% Insiders
16.83% Mutual Funds
13.86% Other Institutional Investors
38.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTKB FAQ
What was Cytek Biosciences’s price range in the past 12 months?
Cytek Biosciences lowest stock price was $4.66 and its highest was $9.33 in the past 12 months.
What is Cytek Biosciences’s market cap?
Cytek Biosciences’s market cap is $669.82M.
When is Cytek Biosciences’s upcoming earnings report date?
Cytek Biosciences’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were Cytek Biosciences’s earnings last quarter?
Cytek Biosciences released its earnings results on Nov 05, 2024. The company reported $0.063 earnings per share for the quarter, beating the consensus estimate of $0.012 by $0.051.
Is Cytek Biosciences overvalued?
According to Wall Street analysts Cytek Biosciences’s price is currently Undervalued.
Does Cytek Biosciences pay dividends?
Cytek Biosciences does not currently pay dividends.
What is Cytek Biosciences’s EPS estimate?
Cytek Biosciences’s EPS estimate is 0.09.
How many shares outstanding does Cytek Biosciences have?
Cytek Biosciences has 128,810,610 shares outstanding.
What happened to Cytek Biosciences’s price movement after its last earnings report?
Cytek Biosciences reported an EPS of $0.063 in its last earnings report, beating expectations of $0.012. Following the earnings report the stock price went up 36.029%.
Which hedge fund is a major shareholder of Cytek Biosciences?
Currently, no hedge funds are holding shares in CTKB
---
Cytek Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.50 (44.23% Upside)
$7.50 (44.23% Upside)
Blogger Sentiment
Bullish
CTKB Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ―
Last 30 Days ―
Last 30 Days ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.94%
12-Months-Change
Fundamentals
Return on Equity
-2.54%
Trailing 12-Months
Asset Growth
-5.43%
Trailing 12-Months
Company Description
Cytek Biosciences
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.
---
CTKB Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment overall, with significant revenue growth driven by strong international performance and positive adjusted EBITDA and net income results. However, challenges were noted in the U.S. market and China, along with increased material costs affecting profit margins.Read More>---
CTKB Stock 12 Month Forecast
Average Price Target
$7.50
▲(44.23% Upside)
Technical Analysis
Best Analysts Covering CTKB
1 Year
1 Year Success Rate
3/20 ratings generated profit
1 Year Average Return
-21.68%
assigned a buy rating 24 days ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -21.68% per trade.
---